Chlamydia pneumoniae infection in patients with cystic fibrosis

Clinical Infectious Diseases

Volumn 22, Issue 5, 1996, Pages 819-823

  Emre, Umit ^b   Bernius, Maureen ^b   Roblin, Patricia M ^b   Gaerlan, Pureza F ^b   Summersgill, James T ^b   Steiner, Philip ^b   Schachter, Julius ^b   Hammerschlag, Margaret R ^a  

^a SUNY DOWNSTATE MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN E;

ADOLESCENT; ADULT; ANTIBODY TITER; ARTICLE; BRONCHUS REACTIVITY; CHILD; CHLAMYDIASIS; CHLAMYDOPHILA PNEUMONIAE; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; FEMALE; HUMAN; IMMUNOBLOTTING; MALE; MYCOPLASMA PNEUMONIA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SPUTUM CULTURE;

EID: 0030035288     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinids/22.5.819     Document Type: Article

References (18)

1. Ong ELC, Ellis ME, Webb AK, et al. Infective respiratory exacerbations in young adults with cystic fibrosis: role of viruses and atypical microorganisms. Thorax 1989;44:739-42.
2. Petersen NT, Høiby N, Mordhorst CH, Lind K, Flensborg EW, Brunn B. Respiratory infections in cystic fibrosis patients caused by virus, chlamydia and mycoplasma - possible synergism with Pseudomonas aeruginosa. Acta Pediatr Scand 1981;70:623-8.
3. Chirgwin K, Roblin PM, Gelling M, Hammerschlag MR, Schachter J. Infection with Chlamydia pneumoniae in Brooklyn. J Infect Dis 1991;163:757-61.
4. Block S, Hedrick J, Hammerschlag MR, Cassell GH, Craft JC. Mycoplasma pneumoniae and Chlamydia pneumoniae in pediatric community-acquired pneumonia: comparative efficacy and safety of clarithromycin vs. erythromycin ethylsuccinate. Pediatr Infect Dis J 1995; 14:471-7.
5. Emre U, Roblin PM, Gelling M, et al. The association of Chlamydia pneumoniae infection and reactive airway disease in children. Arch Pediatr Adolesc Med 1994;148:727-32.
6. Emre U, Sokolovskaya N, Roblin PM, Schachter J, Hammerschlag MR. Detection of anti-Chlamydia pneumoniae IgE in children with reactive airway disease. J Infect Dis 1995;172:265-7.
7. Eggleston PA, Rosenstein BJ, Stackhouse CM, Alexander MF. Airway hyperreactivity in cystic fibrosis: clinical correlates and possible effects on the course of the disease. Chest 1988;94:360-5.
8. Roblin PM, Dumornay W, Hammerschlag MR. Use of HEp-2 cells for improved isolation and passage of Chlamydia pneumoniae. J Clin Microbiol 1992;30:1968-71.
9. Buck GE, O'Hara LC, Summersgill JT. Rapid, sensitive detection of Mycoplasma pneumoniae in simulated clinical specimens by DNA amplification. J Clin Microbiol 1992;30:3280-3.
10. Su CJ, Tryon VV, Baseman JB. Cloning and sequence analysis of cytadhesin P1 gene from Mycoplasma pneumoniae. Infect Immun 1987; 55:3023-9.
11. Armitage P. Statistical methods in medical research. Oxford, England: Blackwell, 1971:207-11.
12. Shwachman H, Kulczycki LL. Long-term study of one hundred five patients with cystic fibrosis: studies made over a five-to-fourteen-year period. Am J Dis Child 1958;96:6-15.
13. Brasfield D, Hicks G, Soong S, Tiller ER. The chest roentgenogram in cystic fibrosis: a new scoring system. Pediatrics 1979;63:24-9.
14. Ekman MR, Leinonen M, Syrjälä H, Linnanmäki E, Kujala P, Saikku P. Evaluation of serological methods in the diagnosis of Chlamydia pneumoniae pneumonia during an epidemic in Finland. Eur J Clin Microbiol Infect Dis 1993;12:756-60.
15. Oski FA, ed. Principles and practice of pediatrics. 2nd ed. Philadelphia: JB Lippincott, 1994:1490-501.
16. Pribble CG, Black PG, Bosso JA, Turner RB. Clinical manifestations of exacerbations of cystic fibrosis associated with nonbacterial infections. J Pediatr 1990;117:200-4.
17. Hammerschlag MR, Chirgwin K, Roblin PM, et al. Persistent infection with Chlamydia pneumoniae following acute respiratory illness. Clin Infect Dis 1992;14:178-82.
18. Hammerschlag MR. Antimicrobial susceptibility and therapy of infections caused by Chlamydia pneumoniae. Antimicrob Agents Chemother 1994;38:1873-8.